Bacterial Disease Diagnostics Market Outlook:
Bacterial Disease Diagnostics Market size was valued at USD 3.71 billion in 2025 and is expected to reach USD 7.94 billion by 2035, registering around 7.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of bacterial disease diagnostics is evaluated at USD 3.97 billion.
The growth of the market can be attributed to the growing incidences of mass food poisoning. In the world, around 600 million fell ill due to the consumption of contaminated food and nearly 33 million lost their lives. Bacterial illness is a leading cause of food poisoning in humans. As consumers become increasingly worried about food safety, the demand for trustworthy bacterial illness diagnostics grows.
In addition to this, one aspect that is expected to drive the growth of the bacterial disease diagnostics market is rising research on new treatments and diagnoses. BARDA has collaborated with the government to help a number of companies research novel infectious disease medications. Ongoing research aids in the identification and description of new bacterial pathogens. Researchers can aid in the development of diagnostic tests for these novel infections, aiding disease control.
Key Bacterial Disease Diagnostics Market Insights Summary:
Regional Highlights:
- North America in the bacterial disease diagnostics market is projected to capture a 35% share by 2035, impelled by rising instances of fatal bacterial infections.
- Asia Pacific is expected to hold a 28% share by 2035, supported by increasing typhoid cases during humid monsoon seasons.
Segment Insights:
- The bacterial skin infections segment in the bacterial disease diagnostics market is projected to account for 45% share by 2035, owing to rising skin problems among the population.
- The hospital segment is anticipated to hold a 40% share by 2035, fueled by increased government investment in hospital infrastructure.
Key Growth Trends:
- Rising Government Initiatives for Better Healthcare
- Increasing Emissions from Vehicles
Major Challenges:
- Lack of Skilled Personnel and Adequate Infrastructure
- Low Awareness Regarding the Diagnosis of Bacterial Diseases
Key Players: Vibrostop Srl, VMC Group, Wuzi Hongyuan Devflex Co., Ltd., ANDRE HVAC International Inc, Enidine Incorporated, Eidos Engineering.
Global Bacterial Disease Diagnostics Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 3.71 billion
- 2026 Market Size: USD 3.97 billion
- Projected Market Size: USD 7.94 billion by 2035
- Growth Forecasts: 7.9% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (35% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, China, United Kingdom
- Emerging Countries: China, India, United States, Japan, Germany
Last updated on : 25 February, 2026
Bacterial Disease Diagnostics Market - Growth Drivers and Challenges
Growth Drivers
-
Rising Government Initiatives for Better Healthcare– In 2021, the World Health Organization started the initiative Global Health and Peaces to address the critical health needs of people and to address 70% of disease outbreaks under this program. Bacterial illness diagnostics are critical for early diagnosis and prompt management of infections, which coincides with the government's preventative healthcare aims.
- Increasing Emissions from Vehicles– Motor vehicles emit around 1.5 billion tonnes of greenhouse gases (GHGs) directly into the atmosphere each year. Poor air quality is linked to respiratory problems as well as compromised immune systems, rendering people more susceptible to bacterial illnesses. Therefore, the growing vehicular emissions will increase the need for bacterial disease diagnostics to treat infections.
- Growing Need for Wastewater Treatment- Around 50% of wastewater generated in the world is carefully treated. To test the effectiveness of water and wastewater treatment, the need for bacterial diagnosis becomes highly important. Screening indicator bacteria levels in wastewater aids in making sure that the outcome of residential and industrial wastewater treatment is safe for discharge into the environment.
Challenges
- Lack of Skilled Personnel and Adequate Infrastructure- Many developing countries do not have well-established infrastructure for advanced diagnostic technologies. Moreover, there is a lack of funds and skilled people to carry on the procedure effectively.
- Low Awareness Regarding the Diagnosis of Bacterial Diseases
- High Cost of Manufacturing
Bacterial Disease Diagnostics Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
7.9% |
|
Base Year Market Size (2025) |
USD 3.71 billion |
|
Forecast Year Market Size (2035) |
USD 7.94 billion |
|
Regional Scope |
|
Bacterial Disease Diagnostics Market Segmentation:
Type Segment Analysis
The bacterial skin infections segment in the bacterial disease diagnostics market is estimated to gain the largest revenue share of about 45% in the year 2035. The growth of the segment can be attributed to the rising skin problem among the people. Skin is the most exposed part of the body, therefore many people get affected by acne, infection, and allergies caused by bacterial growth. Acne is the 8th most common disease in the world and affects around 9% of the total global population.
End User Segment Analysis
Bacterial disease diagnostics market from hospital segment is expected to garner a significant share of around 40% in the year 2035. Hospitals play a significant part in patient care, and good diagnostic procedures are key for guiding treatment plans, improving patient outcomes, and limiting infection spread. Furthermore, the governments of various countries are increasing the budget for setting up hospital infrastructures, which is expected to drive the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Product |
|
|
Technology |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Bacterial Disease Diagnostics Market - Regional Analysis
North American Market Insights
North America industry is predicted to dominate majority revenue share of 35% by 2035, due to rising instances of fatal infections caused by bacteria in the region. The growth of the market can be attributed majorly to the rising instances of fatal infections caused by bacteria in the region. The growing changes in the climatic conditions have led to its warming and have significantly increased the chances of bacterial infections. According to the latest research performed by the University of East Anglia (UEA) in the United Kingdom, the United States has become the hotspot of bacterial illness. The frequency of V. vulnificus infections in the United States has increased from 10 to 80 annually over 30 years.
APAC Market Insights
The Asia Pacific bacterial disease diagnostics market is estimated to be the second largest, registering a share of about 28% by the end of 2035. The growth of the market can be attributed majorly to the rising cases of typhoid in the region. In the rainy season, the climate in India becomes extremely humid, owing to which, every year typhoid cases witness a jump of 30% in the monsoon. The cases are higher in rural regions but in 2023, the cases significantly increased in urban areas as well.
Bacterial Disease Diagnostics Market Players:
- bioMérieux SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Becton, Dickinson and Company
- DiaSorin SpA (Luminex)
- Accelerate Diagnostics Inc.
- Bruker Corp.
- Danaher Corp.
- Torus Biosystems
- GENERI BIOTECH s.r.o.
Recent Developments
- F. Hoffmann-La Roche Ltd. announced the collaboration with Janssen Biotech Inc. to expand its diagnosis portfolio for target therapies. It increases innovation and strengthens diagnostic technology.
- bioMerieux launched the new CE-marking of VIDAS® KUBE™, it is a automated immunoassay system for VIDAS range. This will aid both clinical laboratories and the food industry to serve their customers rapidly.
- Report ID: 5206
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
